A Retrospective Observational Study of Rurioctocog Alfa Pegol in Clinical Practice in the United States

BACKGROUND: Research describing patient experience and outcomes with extended half-life recombinant factor VIII (EHL rFVIII) outside of clinical trials is limited. Real-world rFVIII consumption studies, when people with hemophilia A (PWHA) switch from standard half-life (SHL) to EHL rFVIII, may help...

Descripción completa

Detalles Bibliográficos
Autores principales: Aledort, Louis, Milligan, Scott, Watt, Maureen, Booth, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391008/
https://www.ncbi.nlm.nih.gov/pubmed/32223610
http://dx.doi.org/10.18553/jmcp.2020.26.4.492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391008/
https://www.ncbi.nlm.nih.gov/pubmed/32223610
http://dx.doi.org/10.18553/jmcp.2020.26.4.492

Ejemplares similares